Literature DB >> 15108197

Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome.

S M White1, E M Thompson, A Kidd, R Savarirayan, A Turner, D Amor, M B Delatycki, M Fahey, A Baxendale, S White, E Haan, K Gibson, J L Halliday, A Bankier.   

Abstract

This study was undertaken to document the phenotype of Kabuki (Niikawa-Kuroki) syndrome in patients from Australia and New Zealand, with particular emphasis on growth patterns, behavior, and relationship between head circumference and intellectual level. Data on 27 children and adults with Kabuki (Niikawa-Kuroki) syndrome from Australia and New Zealand were collected by questionnaire and clinical assessment. The patients ranged in age from 7 months to 36 years with a mean age of 7 years and 2 months. The mean age at diagnosis was 3(5/6) years, but in most cases, the facial phenotype was evident from infancy. The minimum birth prevalence was calculated at 1 in 86,000. Three of our patients died. Parents reported a behavior phenotype characterized by an excellent long-term memory and avoidance of eye contact. No correlation was found between head circumference and severity of intellectual disability. Eight of 14 patients over the age of 5 years were overweight or obese. Six of these eight patients had failure to thrive in infancy. One patient developed insulin-dependent diabetes mellitus in adolescence. Some individuals with Kabuki (Niikawa-Kuroki) syndrome show a characteristic growth profile with failure to thrive in infancy progressing to obesity or overweight in middle childhood or adolescence. A behavior phenotype was noted which requires further investigation. Head size is not a predictor of degree of intellectual disability. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15108197     DOI: 10.1002/ajmg.a.20674

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

Review 1.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

2.  Precocious chondrocyte differentiation disrupts skeletal growth in Kabuki syndrome mice.

Authors:  Jill A Fahrner; Wan-Ying Lin; Ryan C Riddle; Leandros Boukas; Valerie B DeLeon; Sheetal Chopra; Susan E Lad; Teresa Romeo Luperchio; Kasper D Hansen; Hans T Bjornsson
Journal:  JCI Insight       Date:  2019-10-17

3.  The C20orf133 gene is disrupted in a patient with Kabuki syndrome.

Authors:  Nicole M C Maas; Tom Van de Putte; Cindy Melotte; Annick Francis; Constance T R M Schrander-Stumpel; Damien Sanlaville; David Genevieve; Stanislas Lyonnet; Boyan Dimitrov; Koenraad Devriendt; Jean-Pierre Fryns; Joris R Vermeesch
Journal:  BMJ Case Rep       Date:  2009-06-30

4.  Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome.

Authors:  Mark C Hannibal; Kati J Buckingham; Sarah B Ng; Jeffrey E Ming; Anita E Beck; Margaret J McMillin; Heidi I Gildersleeve; Abigail W Bigham; Holly K Tabor; Heather C Mefford; Joseph Cook; Koh-ichiro Yoshiura; Tadashi Matsumoto; Naomichi Matsumoto; Noriko Miyake; Hidefumi Tonoki; Kenji Naritomi; Tadashi Kaname; Toshiro Nagai; Hirofumi Ohashi; Kenji Kurosawa; Jia-Woei Hou; Tohru Ohta; Deshung Liang; Akira Sudo; Colleen A Morris; Siddharth Banka; Graeme C Black; Jill Clayton-Smith; Deborah A Nickerson; Elaine H Zackai; Tamim H Shaikh; Dian Donnai; Norio Niikawa; Jay Shendure; Michael J Bamshad
Journal:  Am J Med Genet A       Date:  2011-06-10       Impact factor: 2.802

5.  Strabismus and poor stereoacuity associated with Kabuki syndrome.

Authors:  Nam Gil Kim; Hyon J Kim; Jeong-Min Hwang
Journal:  Korean J Ophthalmol       Date:  2011-03-11

6.  Neonatal maternal deprivation response and developmental changes in gene expression revealed by hypothalamic gene expression profiling in mice.

Authors:  Feng Ding; Hong Hua Li; Jun Li; Richard M Myers; Uta Francke
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

7.  The C20orf133 gene is disrupted in a patient with Kabuki syndrome.

Authors:  Nicole M C Maas; Tom Van de Putte; Cindy Melotte; Annick Francis; Constance T R M Schrander-Stumpel; Damien Sanlaville; David Genevieve; Stanislas Lyonnet; Boyan Dimitrov; Koenraad Devriendt; Jean-Pierre Fryns; Joris R Vermeesch
Journal:  J Med Genet       Date:  2007-06-23       Impact factor: 6.318

Review 8.  Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management.

Authors:  Senthil Senniappan; Balasubramaniam Shanti; Chela James; Khalid Hussain
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

Review 9.  Kabuki syndrome: clinical and molecular characteristics.

Authors:  Chong-Kun Cheon; Jung Min Ko
Journal:  Korean J Pediatr       Date:  2015-09-21

10.  Persistent Hyperinsulinism in Kabuki Syndrome 2: Case Report and Literature Review.

Authors:  Hobia Gole; Raymond Chuk; David Coman
Journal:  Clin Pract       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.